Ansh Labs
Felipe Villasenor has a diverse work experience in finance and technology roles. Felipe worked at Ansh Labs as the EVP Finance Technology, where they performed capital expenditure and cash flow modeling, streamlined business processes to increase cash flow, and led the implementation of SAP Business ByDesign as the new ERP system. Prior to that, Felipe worked as the Vice President of Finance at Cachinko, where they raised $4.5 million in equity, led finance and accounting initiatives, and performed financial reporting analysis. Felipe also served as the Finance Director & Controller at Diagnostic Systems Laboratories, where they managed relationships with banks, auditing firms, and lawyers, led SAP R/3 ERP projects, and performed vendor selection and procurement.
Felipe Villasenor completed their Master of Business Administration (M.B.A.) in Finance & Strategy from Rice Business - Jones Graduate School of Business from 2013 to 2015. Prior to that, they obtained their Bachelor of Business Administration (BBA) in Finance from Texas McCombs School of Business from 1995 to 1998. Additionally, Felipe Villasenor also holds a certification as a Project Management Professional (PMP) from the Project Management Institute, which they obtained in February 2013.
This person is not in any teams
Ansh Labs
Ansh Labs is a leading developer and manufacturer of immunodiagnostic assays and reagents used to advance target discovery, therapeutic development, biomedical research, and clinical diagnostics. We serve life science researchers, physician researchers, hospitals, commercial laboratories, and public health agencies to assist with the research, diagnosis, treatment, and management of diseases. The products we develop make it possible to conduct ground-breaking research in cardiovascular health, growth hormone disorders, cancer, fertility dysfunction, neurodegenerative disease, and pregnancy health. Our scientists and advisors are experts in immunoassay development. We offer contract development and custom manufacturing services of novel immunoassays and specialty reagents for diagnostics and biotechnology research and discovery. We also provide assay validation and diagnostic testing services for clinical trials to pharmaceutical companies.